AAAAAA

   
Results: 1-25 | 26-45 |
Results: 26-45/45
USFDA advisory panel urges ban on UK blood
Authors: Ault, A
Citation: A. Ault, USFDA advisory panel urges ban on UK blood, LANCET, 353(9169), 1999, pp. 2050-2050
Pharmaceutical companies pay criminal fine for global price fixing
Authors: Ault, A
Citation: A. Ault, Pharmaceutical companies pay criminal fine for global price fixing, LANCET, 353(9167), 1999, pp. 1862-1862
Rheumatoid-arthritis drug linked to infections
Authors: Ault, A
Citation: A. Ault, Rheumatoid-arthritis drug linked to infections, LANCET, 353(9166), 1999, pp. 1770-1770
USA starts to identify blood recipients at risk from hepatitis C
Authors: Ault, A
Citation: A. Ault, USA starts to identify blood recipients at risk from hepatitis C, LANCET, 353(9165), 1999, pp. 1686-1686
COX-2 inhibitors take one step forward - and one back
Authors: Ault, A
Citation: A. Ault, COX-2 inhibitors take one step forward - and one back, LANCET, 353(9163), 1999, pp. 1503-1503
Drug company plans to sell anticholesterol drug over-the-counter
Authors: Ault, A McMenemy, MC
Citation: A. Ault et Mc. Mcmenemy, Drug company plans to sell anticholesterol drug over-the-counter, LANCET, 353(9161), 1999, pp. 1339-1339
Troglitazone ban loses support
Authors: Ault, A
Citation: A. Ault, Troglitazone ban loses support, LANCET, 353(9159), 1999, pp. 1161-1161
New direction for treatment of rheumatoid arthritis offered in USA
Authors: Ault, A
Citation: A. Ault, New direction for treatment of rheumatoid arthritis offered in USA, LANCET, 353(9158), 1999, pp. 1071-1071
Institute of Medicine says marijuana has benefits
Authors: Ault, A
Citation: A. Ault, Institute of Medicine says marijuana has benefits, LANCET, 353(9158), 1999, pp. 1077-1077
New influenza therapy voted down by FDA panelists
Authors: Ault, A
Citation: A. Ault, New influenza therapy voted down by FDA panelists, LANCET, 353(9155), 1999, pp. 816-816
US panel backs 24-hour glucose monitor
Authors: Ault, A
Citation: A. Ault, US panel backs 24-hour glucose monitor, LANCET, 353(9155), 1999, pp. 822-822
Pressure group calls for recall of urokinase
Authors: Ault, A
Citation: A. Ault, Pressure group calls for recall of urokinase, LANCET, 353(9153), 1999, pp. 652-652
National Institutes of Health to fund stem-cell research
Authors: Ault, A
Citation: A. Ault, National Institutes of Health to fund stem-cell research, LANCET, 353(9150), 1999, pp. 390-390
US FDA advisers back new myopia aid
Authors: Ault, A
Citation: A. Ault, US FDA advisers back new myopia aid, LANCET, 353(9149), 1999, pp. 300-300
FDA approves first new narcolepsy drug in USA in decades
Authors: Ault, A
Citation: A. Ault, FDA approves first new narcolepsy drug in USA in decades, LANCET, 353(9147), 1999, pp. 131-131
FDA urged to defer donations by UK residents
Authors: Ault, A
Citation: A. Ault, FDA urged to defer donations by UK residents, LANCET, 353(9146), 1999, pp. 49-49
Do pH in your head
Authors: Ault, A
Citation: A. Ault, Do pH in your head, J CHEM EDUC, 76(7), 1999, pp. 936-938
The yeast histidine protein kinase, Sln1p, mediates phosphotransfer to tworesponse regulators, Ssk1p and Skn7p
Authors: Li, S Ault, A Malone, CL Raitt, D Dean, S Johnston, LH Deschenes, RJ Fassler, JS
Citation: S. Li et al., The yeast histidine protein kinase, Sln1p, mediates phosphotransfer to tworesponse regulators, Ssk1p and Skn7p, EMBO J, 17(23), 1998, pp. 6952-6962
FDA approves two new hepatitis therapies
Authors: Ault, A
Citation: A. Ault, FDA approves two new hepatitis therapies, LANCET, 352(9145), 1998, pp. 1996-1996
First COX-2 inhibitor clears initial FDA hurdle
Authors: Ault, A
Citation: A. Ault, First COX-2 inhibitor clears initial FDA hurdle, LANCET, 352(9144), 1998, pp. 1912-1912
Risultati: 1-25 | 26-45 |